## Distinction Between Serous Cystadenoma and Serous Cystadenocarcinoma ### Key Discriminating Feature **Key Point:** The defining difference between benign and malignant serous tumours is **stromal invasion** and **loss of basement membrane integrity**. Cystadenomas are confined to the epithelial layer with an intact basement membrane, while cystadenocarcinomas show frank invasion into the ovarian stroma. ### Comparative Histology | Feature | Serous Cystadenoma | Serous Cystadenocarcinoma | |---------|-------------------|---------------------------| | **Stromal invasion** | Absent | Present (hallmark of malignancy) | | **Basement membrane** | Intact | Breached/disrupted | | **Epithelial stratification** | Single layer (simple cuboidal/columnar) | Multilayered, complex architecture | | **Nuclear atypia** | Minimal | Marked (high grade) | | **Psammoma bodies** | May be present | May be present | | **Ciliated epithelium** | Present | May be present | | **Cyst architecture** | Unilocular or multilocular | Multilocular (often) | ### Why Stromal Invasion Is the Gold Standard **High-Yield:** In ovarian epithelial tumours, the presence or absence of stromal invasion is the **single most reliable criterion** for distinguishing benign from malignant lesions. This is true across all histological types (serous, mucinous, endometrioid, clear cell). **Clinical Pearl:** Psammoma bodies, ciliated epithelium, and multilocular architecture can all be seen in BOTH benign and malignant serous tumours and therefore cannot be used as discriminators. ### Grading of Serous Cystadenocarcinomas - **Low-grade (LGSC):** Mild nuclear atypia, slow growth, better prognosis - **High-grade (HGSC):** Marked nuclear pleomorphism, high mitotic rate, aggressive behaviour **Warning:** Do not confuse the presence of psammoma bodies with malignancy — they are a feature of serous differentiation and can occur in benign tumours. [cite:Robbins 10e Ch 22] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.